You'll be hearing about Project ImPACT

You'll be hearing about Project ImPACT...a two-year study to show how pharmacists can improve compliance in patients on cholesterol-lowering therapy.

It's being conducted by APhA and funded by Merck.

Pharmacists will use a nifty Cholestech machine. It determines cholesterol levels from a fingerstick blood sample...then calculates the patient's risk of developing coronary heart disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote